Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer

Biochemical and Biophysical Research Communications

Volumn 385, Issue 3, 2009, Pages 307-313

  Chen, Yu Chih ^a   Chen, Yi Wei ^a,b   Hsu, Han Shui ^a,b   Tseng, Ling Ming ^a,b   Huang, Pin I ^a,b   Lu, Kai Hsi ^a,b   Chen, Dow Tien ^a,b   Tai, Lung Kuo ^a,b   Yung, Ming Chi ^a,c   Chang, Shih Ching ^a,b   Ku, Hung Hai ^a,c   Chiou, Shih Hwa ^a,b   Lo, Wen Liang ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c Zhongxiao Branch ^*  (Taiwan)

Author keywords

Aldehyde dehydrogenase 1; Cancer stem cell; Head and neck squamous cancer

Indexed keywords

ALDEHYDE DEHYDROGENASE; TRANSCRIPTION FACTOR SNAIL; TUMOR MARKER;

ARTICLE; CANCER STEM CELL; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; WESTERN BLOTTING;

AGED; ALDEHYDE DEHYDROGENASE; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE KNOCKDOWN TECHNIQUES; HEAD AND NECK NEOPLASMS; HUMANS; ISOENZYMES; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

GASTROPODA;

EID: 67349209852     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.05.048     Document Type: Article

References (24)

1. Kamangar F., Dores G.M., and Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol. 24 (2006) 2137-2150
2. Khawaja M.R., Mazahir S., Majeed A., Malik F., Merchant K.A., Maqsood M., Malik R., Ghaffar S., and Fatmi Z. Chewing of betel, areca and tobacco: perceptions and knowledge regarding their role in head and neck cancers in an urban squatter settlement in Pakistan. Asian Pac. J. Cancer Prev. 7 (2006) 95-100
3. Lo W.L., Kao S.Y., Chi L.Y., Wong Y.K., and Chang R.C. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J. Oral Maxillofac. Surg. 61 (2003) 751-758
4. Chen Y.C., Hsu H.S., Chen Y.W., Tsai T.H., How C.K., Wang C.Y., Hung S.C., Chang Y.L., Tsai M.L., Lee Y.Y., Ku H.H., and Chiou S.H. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS ONE 3 (2008) e2637
5. Chiou S.H., Yu C.C., Huang C.Y., Lin S.C., Liu C.J., Tsai T.H., Chou S.H., Chien C.S., Ku H.H., and Lo J.F. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin. Cancer Res. 14 (2008) 4085-4095
6. Mack B., and Gires O. CD44s and CD44v6 expression in head and neck epithelia. PLoS ONE 3 (2008) e3360
7. Sheridan C., Kishimoto H., Fuchs R.K., Mehrotra S., Bhat-Nakshatri P., Turner C.H., Goulet Jr. R., Badve S., and Nakshatri H. CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res. 8 (2006) R59
8. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., Weissman I.L., Clarke M.F., and Ailles L.E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 104 (2007) 973-978
9. Yoshida A. Molecular genetics of human aldehyde dehydrogenase. Pharmacogenetics 2 (1992) 139-147
10. Lindahl R. Aldehyde dehydrogenases and their role in carcinogenesis. Crit. Rev. Biochem. Mol. Biol. 27 (1992) 283-335
11. Armstrong L., Stojkovic M., Dimmick I., Ahmad S., Stojkovic P., Hole N., and Lako M. Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells 22 (2004) 1142-1151
12. Hess D.A., Meyerrose T.E., Wirthlin L., Craft T.P., Herrbrich P.E., Creer M.H., and Nolta J.A. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 104 (2004) 1648-1655
13. Visus C., Ito D., Amoscato A., Maciejewska-Franczak M., Abdelsalem A., Dhir R., Shin D.M., Donnenberg V.S., Whiteside T.L., and DeLeo A.B. Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. Cancer Res. 67 (2007) 10538-10545
14. Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., Jacquemier J., Viens P., Kleer C.G., Liu S., Schott A., Hayes D., Birnbaum D., Wicha M.S., and Dontu G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1 (2007) 555-567
15. Ma S., Chan K.W., Lee T.K., Tang K.H., Wo J.Y., Zheng B.J., and Guan X.Y. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol. Cancer Res. 6 (2008) 1146-1153
16. Huang E.H., Hynes M.J., Zhang T., Ginestier C., Dontu G., Appelman H., Fields J.Z., Wicha M.S., and Boman B.M. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. (2009)
17. Jiang F., Qiu Q., Khanna A., Todd N.W., Deepak J., Xing L., Wang H., Liu Z., Su Y., Stass S.A., and Katz R.L. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol. Cancer Res. 7 (2009) 330-338
18. Thiery J.P., and Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7 (2006) 131-142
19. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., and Weinberg R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 (2008) 704-715
20. Batlle E., Sancho E., Franci C., Dominguez D., Monfar M., Baulida J., and Garcia De Herreros A. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2 (2000) 84-89
21. Zhou B.P., Deng J., Xia W., Xu J., Li Y.M., Gunduz M., and Hung M.C. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 6 (2004) 931-940
22. Dalerba P., Cho R.W., and Clarke M.F. Cancer stem cells: models and concepts. Annu. Rev. Med. 58 (2007) 267-284
23. Karnoub A.E., Dash A.B., Vo A.P., Sullivan A., Brooks M.W., Bell G.W., Richardson A.L., Polyak K., Tubo R., and Weinberg R.A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449 (2007) 557-563
24. Spaeth E.L., Dembinski J.L., Sasser A.K., Watson K., Klopp A., Hall B., Andreeff M., and Marini F. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS ONE 4 (2009) e4992